Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide with AD and High-Dose Melphalan in Multiple Myeloma
NCT00028886Phase 3Unknown
- Sponsor
- Commissie voor Klinisch Toegepast Onderzoek
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by Commissie voor Klinisch Toegepast Onderzoek. Status: unknown.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00028886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028886.